Sundrug Co Ltd
TSE:9989
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3 440
4 890
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sundrug Co Ltd
Net Issuance of Common Stock
Sundrug Co Ltd
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Sundrug Co Ltd
TSE:9989
|
Net Issuance of Common Stock
ÂĄ0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Tsuruha Holdings Inc
TSE:3391
|
Net Issuance of Common Stock
ÂĄ0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Welcia Holdings Co Ltd
TSE:3141
|
Net Issuance of Common Stock
ÂĄ2.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-15%
|
||
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Net Issuance of Common Stock
-ÂĄ1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Net Issuance of Common Stock
-ÂĄ3.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
23%
|
CAGR 10-Years
-87%
|
||
Cosmos Pharmaceutical Corp
TSE:3349
|
Net Issuance of Common Stock
ÂĄ0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Sundrug Co Ltd
Glance View
Sundrug Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Fuchu-Shi, Tokyo-To and currently employs 5,634 full-time employees. The Drug Store segment is primarily engaged in the sale of pharmaceutical products, cosmetic products and sundry goods, among others. The Discount Store segment is primarily engaged in the sale of foodstuffs, household sundry goods, among others.
See Also
What is Sundrug Co Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
0
JPY
Based on the financial report for Jun 30, 2024, Sundrug Co Ltd's Net Issuance of Common Stock amounts to 0 JPY.